Anas M Alazami1, Mohammed Zain Seidahmed2, Fatema Alzahrani1, Adam O Mohammed3, Fowzan S Alkuraya4. 1. Department of Genetics, King Faisal Specialist Hospital and Research Center Riyadh, Saudi Arabia. 2. Department of Pediatrics, Security Forces Hospital Riyadh, Saudi Arabia. 3. Department of Pediatrics, National Guard Hospital Dammam, Saudi Arabia. 4. Department of Genetics, King Faisal Specialist Hospital and Research Center Riyadh, Saudi Arabia ; Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University Riyadh, Saudi Arabia.
Abstract
Cranioectodermal dysplasia (CED) is a very rare autosomal recessive disorder characterized by a recognizable craniofacial profile in addition to ectodermal manifestations involving the skin, hair, and teeth. Four genes are known to be mutated in this disorder, all involved in the ciliary intraflagellar transport confirming that CED is a ciliopathy. In a multiplex consanguineous family with typical CED features in addition to intellectual disability and severe cutis laxa, we used autozygosity-guided candidate gene analysis to identify a novel homozygous mutation in IFT122, and demonstrated impaired ciliogenesis in patient fibroblasts. This report on IFT122 broadens the phenotype of CED and expands its allelic heterogeneity.
Cranioectodermal dysplasia (CED) is a very rare autosomal recessive disorder characterized by a recognizable craniofacial profile in addition to ectodermal manifestations involving the skin, hair, and teeth. Four genes are known to be mutated in this disorder, all involved in the ciliary intraflagellar transport confirming that CED is a ciliopathy. In a multiplex consanguineous family with typical CED features in addition to intellectual disability and severe cutis laxa, we used autozygosity-guided candidate gene analysis to identify a novel homozygous mutation in IFT122, and demonstrated impaired ciliogenesis in patient fibroblasts. This report on IFT122 broadens the phenotype of CED and expands its allelic heterogeneity.
Entities:
Keywords:
Ciliopathy; craniosynostosis; intraflagellar transport
Cranioectodermal dysplasia (CED) is a skeletal dysplasia characterized by typical craniofacial features in the form of dolichocephaly, sagittal craniosynostosis, and facial dysmorphism (frontal bossing, epicanthic folds, flat nose with anteverted nares, and everted lower lip), and skeletal anomalies in the form of narrow thorax and short extremities, in addition to ectodermal dysplastic features in the form of thin sparse scalp hair and micro/hypodontia (Levin et al. 1977). Since its first description in 1975 (Sensenbrenner et al. 1975), less than 50 cases have been reported indicating the rarity of this syndrome. The subsequent expansion of the phenotype to include corpus callosal dysgenesis, hepatic fibrosis, nephrophthisis, and retinitis pigmentosa made it likely that CED is a ciliopathy (Konstantinidou et al. 2009). Indeed, genetic studies confirmed this hypothesis by identifying mutations in four genes all encoding components of the ciliary intraflagellar transport complex-A (IFT122,WDR35,C14ORF179, and WDR19) (Gilissen et al. 2010; Walczak-Sztulpa et al. 2010; Arts et al. 2011; Bredrup et al. 2011). Not unlike other ciliopathy disease genes, mutations in some of these genes have been observed to cause overlapping ciliopathy phenotypes such as the finding of WDR35 mutations in short rib-polydactyly syndrome (Mill et al. 2011). Thus, additional reports of mutations in these genes will be critical to our understanding of the spectrum of resulting phenotypes.In this report, we describe a multiplex family containing three affected siblings born to healthy first cousin Saudi parents (Fig. 1A). In addition to the classical features of CED (Table 1, Fig. 1B and C), they all had markedly lax skin with joint laxity fulfilling the clinical definition of cutis laxa, but none had evidence of retinal involvement and only the oldest patient developed end-stage renal failure. In addition, the two older siblings have confirmed intellectual disability with intelligence quotient of 70, a feature that has not been reported in CED. Given the consanguinity of the parents and the genetic heterogeneity of CED, we pursued autozygome-guided candidate gene sequencing essentially as described before (Alkuraya 2012). The autozygome of the three siblings overlapped on just two genomic regions (chr3:102718000-136160000, and chr11:13395000-27766000, hg19 build) (Fig. 2A). IFT122 was the only known CED disease gene mapping to either of the two regions. Direct sequencing of IFT122 revealed a novel homozygous missense mutation (c.1868G>T, p.G623V; NM_052985.2) (Fig. 2B). The affected amino acid residue is highly conserved across species (Fig. 2D), is associated with high in silico pathogenicity scores (PolyPhen 1.0 and SIFT 0.0) and was absent from 374 Saudi control chromosomes.
Figure 1
The family reported in this study. (A) Pedigree of the family with the index case boxed in red. Facial and hand profiles for the two male patients are given in (B) and (C). Note the typical facial features (prominent forehead, depressed nasal bridge, anteverted nares, and everted lower lip) and typical hand features (brachdactyly, single interphalangeal crease for some fingers and clinodactyly). Please note the redundant palm skin in the lower panels, consistent with cutis laxa.
Table 1
Clinical features.
Clinical feature
Patient 1
Patient 2
Patient 3
Age
22 years
9 years
2 years
Frequent chest infection
Female
Male
Male
Sagittal craniosynostosis
+
+
+
Dolichocephaly
+
−
+
Epicanthal folds
+
+
+
Broad nasal bridge
+
+
+
Anteverted nares
+
+
+
Everted lower lip
−
−
−
Micro/Hypodontia
+
+
+
Narrow thorax
+
−
+
Short limbs
+
+
+
Brachydactyly
+
+
+
Clinodactyly
+
+
+
Joint hypermobility
+
+
+
Cutis laxa
+
+
+
Osteoporosis
?
−
−
Retinal dystrophy
−
−
−
Nephronophthisis
ESRF
−
−
Congenital heart disease
−
−
−
Frequent chest infection
+
+
+
Others
ID
ID
−
ESRF, end stage renal failure; ID, intellectual disability; ?, unknown.
Figure 2
A missense mutation in IFT122 causes cranioectodermal dysplasia in the reported family. (A) Homozygosity Mapper reveals two regions of autozygosity which are shared by the three patients genomewide. The IFT122 locus is indicated with an arrow. (B) Sequence chromatogram of one control individual and one patient, with the site of mutation denoted by an asterisk. (C) Schematic of the IFT122 protein indicating the position of WD40 domains. The mutation reported here is located with a green arrow, while all previously published mutations are given below the schematic (red arrowheads). (D) Protein alignment data reveal that the affected amino acid residue is highly conserved across species, down to moss and trichoplax.
Clinical features.ESRF, end stage renal failure; ID, intellectual disability; ?, unknown.The family reported in this study. (A) Pedigree of the family with the index case boxed in red. Facial and hand profiles for the two male patients are given in (B) and (C). Note the typical facial features (prominent forehead, depressed nasal bridge, anteverted nares, and everted lower lip) and typical hand features (brachdactyly, single interphalangeal crease for some fingers and clinodactyly). Please note the redundant palm skin in the lower panels, consistent with cutis laxa.A missense mutation in IFT122 causes cranioectodermal dysplasia in the reported family. (A) Homozygosity Mapper reveals two regions of autozygosity which are shared by the three patients genomewide. The IFT122 locus is indicated with an arrow. (B) Sequence chromatogram of one control individual and one patient, with the site of mutation denoted by an asterisk. (C) Schematic of the IFT122 protein indicating the position of WD40 domains. The mutation reported here is located with a green arrow, while all previously published mutations are given below the schematic (red arrowheads). (D) Protein alignment data reveal that the affected amino acid residue is highly conserved across species, down to moss and trichoplax.In order to confirm the pathogenicity of this mutation, we cultured fibroblasts from the foreskin of the younger brother following circumcision and proceeded with stress-induced ciliogenesis assay, essentially as described before (Shaheen et al. 2012). In addition to observing a marked reduction in ciliated fibroblasts, existing cilia in patient fibroblasts were also smaller compared to control age-matched fibroblasts (Fig. 3A and B). These reductions in ciliary frequency and length were confirmed to be highly significant (Fig. 3C and D). Thus, it appears that G623V is associated with a similar ciliogenesis defect to the ones reported in the original description of IFT122 as a novel CED disease gene (Walczak-Sztulpa et al. 2010). The molecular confirmation of CED in this expands the allelic heterogeneity of IFT122 in CED (Tsurusaki et al. 2013). In addition, the remarkable cutis laxa phenotype in this family supports one previous report of CED with cutis laxa (Fry et al. 2009) thus confirming that this is a bona fide phenotypic aspect of the disease albeit at low frequency. Finally, this is the first instance of confirmed intellectual disability in CED, which suggests that intellectual disability may be a low-frequency feature of this disorder.
Figure 3
Primary cilia in patient cells exhibit reduced frequency and length as compared with control cells. Primary cilia from serum-starved primary control (A) and patient (B) fibroblasts, stained with anti-acetylated tubulin (green) and counterstained with 4',6-diamidino-2-phenylindole (blue). (C) Patient cells show significantly decreased ciliogenesis versus control cells (P < 0.0001, Fisher's exact test). All cells within a total of six fields, representing two independent experiments, were counted for each cell line. Error bars represent the standard error of the mean. (D) Patient cells show significantly decreased ciliary length versus control cells (P < 0.002, unpaired t-test). Error bars represent the standard error of the mean.
Primary cilia in patient cells exhibit reduced frequency and length as compared with control cells. Primary cilia from serum-starved primary control (A) and patient (B) fibroblasts, stained with anti-acetylated tubulin (green) and counterstained with 4',6-diamidino-2-phenylindole (blue). (C) Patient cells show significantly decreased ciliogenesis versus control cells (P < 0.0001, Fisher's exact test). All cells within a total of six fields, representing two independent experiments, were counted for each cell line. Error bars represent the standard error of the mean. (D) Patient cells show significantly decreased ciliary length versus control cells (P < 0.002, unpaired t-test). Error bars represent the standard error of the mean.
Authors: Cecilie Bredrup; Sophie Saunier; Machteld M Oud; Torunn Fiskerstrand; Alexander Hoischen; Damien Brackman; Sabine M Leh; Marit Midtbø; Emilie Filhol; Christine Bole-Feysot; Patrick Nitschké; Christian Gilissen; Olav H Haugen; Jan-Stephan F Sanders; Irene Stolte-Dijkstra; Dorus A Mans; Eric J Steenbergen; Ben C J Hamel; Marie Matignon; Rolph Pfundt; Cécile Jeanpierre; Helge Boman; Eyvind Rødahl; Joris A Veltman; Per M Knappskog; Nine V A M Knoers; Ronald Roepman; Heleen H Arts Journal: Am J Hum Genet Date: 2011-10-20 Impact factor: 11.025
Authors: Christian Gilissen; Heleen H Arts; Alexander Hoischen; Liesbeth Spruijt; Dorus A Mans; Peer Arts; Bart van Lier; Marloes Steehouwer; Jeroen van Reeuwijk; Sarina G Kant; Ronald Roepman; Nine V A M Knoers; Joris A Veltman; Han G Brunner Journal: Am J Hum Genet Date: 2010-09-10 Impact factor: 11.025
Authors: Heleen H Arts; Ernie M H F Bongers; Dorus A Mans; Sylvia E C van Beersum; Machteld M Oud; Emine Bolat; Liesbeth Spruijt; Elisabeth A M Cornelissen; Janneke H M Schuurs-Hoeijmakers; Nicole de Leeuw; Valérie Cormier-Daire; Han G Brunner; Nine V A M Knoers; Ronald Roepman Journal: J Med Genet Date: 2011-03-04 Impact factor: 6.318
Authors: Y Tsurusaki; R Yonezawa; M Furuya; G Nishimura; R K Pooh; M Nakashima; H Saitsu; N Miyake; S Saito; N Matsumoto Journal: Clin Genet Date: 2013-07-05 Impact factor: 4.438
Authors: Joanna Walczak-Sztulpa; Jonathan Eggenschwiler; Daniel Osborn; Desmond A Brown; Francesco Emma; Claus Klingenberg; Raoul C Hennekam; Giuliano Torre; Masoud Garshasbi; Andreas Tzschach; Malgorzata Szczepanska; Marian Krawczynski; Jacek Zachwieja; Danuta Zwolinska; Philip L Beales; Hans-Hilger Ropers; Anna Latos-Bielenska; Andreas W Kuss Journal: Am J Hum Genet Date: 2010-05-20 Impact factor: 11.025
Authors: Anastasia E Konstantinidou; Helen Fryssira; Stavros Sifakis; Charalampos Karadimas; Petros Kaminopetros; Georgios Agrogiannis; Stylianos Velonis; Peter G J Nikkels; Efstratios Patsouris Journal: Am J Med Genet A Date: 2009-10 Impact factor: 2.802
Authors: Pleasantine Mill; Paul J Lockhart; Elizabeth Fitzpatrick; Hayley S Mountford; Emma A Hall; Martin A M Reijns; Margaret Keighren; Melanie Bahlo; Catherine J Bromhead; Peter Budd; Salim Aftimos; Martin B Delatycki; Ravi Savarirayan; Ian J Jackson; David J Amor Journal: Am J Hum Genet Date: 2011-04-08 Impact factor: 11.025
Authors: M Hampl; P Cela; H L Szabo-Rogers; M Kunova Bosakova; H Dosedelova; P Krejci; M Buchtova Journal: J Dent Res Date: 2017-06-12 Impact factor: 6.116
Authors: Anas M Alazami; Sarah M Al-Qattan; Eissa Faqeih; Amal Alhashem; Muneera Alshammari; Fatema Alzahrani; Mohammed S Al-Dosari; Nisha Patel; Afaf Alsagheir; Bassam Binabbas; Hamad Alzaidan; Abdulmonem Alsiddiky; Nasser Alharbi; Majid Alfadhel; Amal Kentab; Riza M Daza; Martin Kircher; Jay Shendure; Mais Hashem; Saif Alshahrani; Zuhair Rahbeeni; Ola Khalifa; Ranad Shaheen; Fowzan S Alkuraya Journal: Hum Genet Date: 2016-03-29 Impact factor: 4.132
Authors: Bailey A Allard; Wei Wang; Tana S Pottorf; Hammad Mumtaz; Brittany M Jack; Henry H Wang; Luciane M Silva; Damon T Jacobs; Jinxi Wang; Erin E Bumann; Pamela V Tran Journal: Cell Mol Life Sci Date: 2021-03-08 Impact factor: 9.207
Authors: Anna A W M Sanders; Erik de Vrieze; Anas M Alazami; Fatema Alzahrani; Erik B Malarkey; Nasrin Sorusch; Lars Tebbe; Stefanie Kuhns; Teunis J P van Dam; Amal Alhashem; Brahim Tabarki; Qianhao Lu; Nils J Lambacher; Julie E Kennedy; Rachel V Bowie; Lisette Hetterschijt; Sylvia van Beersum; Jeroen van Reeuwijk; Karsten Boldt; Hannie Kremer; Robert A Kesterson; Dorota Monies; Mohamed Abouelhoda; Ronald Roepman; Martijn H Huynen; Marius Ueffing; Rob B Russell; Uwe Wolfrum; Bradley K Yoder; Erwin van Wijk; Fowzan S Alkuraya; Oliver E Blacque Journal: Genome Biol Date: 2015-12-29 Impact factor: 13.583